Added to YB: 2024-06-20
Pitch date: 2024-06-20
HROW [bullish]
Harrow, Inc.
+153.47%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products.
Market Cap
$1.9B
Pitch Price
$20.05
Price Target
N/A
Dividend
N/A
EV/EBITDA
42.87
P/E
-368.75
EV/Sales
8.18
Sector
Pharmaceuticals
Category
N/A
Show full summary:
Harrow, Inc. HROW
A summary for this pitch has not been created yet.
Read full article (0 min)